Enfusion Market Risk Adjusted Performance
| ENFNDelisted Stock | | | USD 10.76 0.00 0.00% |
Reference data associated with the Market Risk Adjusted Performance technical indicator for Enfusion. Additional screening context is available through
Equity Screeners.
Enfusion has current Market Risk Adjusted Performance of 0.1225.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0.1225 | |
| ER[a] | = | Expected return on investing in Enfusion |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Enfusion lands at
#2 in market risk adjusted performance compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors producing
51.07 in Maximum Drawdown for each unit of Market Risk Adjusted Performance. The spread between Maximum Drawdown and Market Risk Adjusted Performance for Enfusion sits at
51.07 Other Technical Indicators